tiprankstipranks
Enlivex announces enrollment, dosing of first 10 patients in Allocetra trial
PremiumThe FlyEnlivex announces enrollment, dosing of first 10 patients in Allocetra trial
13d ago
Enlivex Therapeutics Reschedules Annual Shareholders Meeting
Premium
Company Announcements
Enlivex Therapeutics Reschedules Annual Shareholders Meeting
25d ago
Enlivex Secures Japanese Patent for Osteoarthritis Therapy
Premium
Company Announcements
Enlivex Secures Japanese Patent for Osteoarthritis Therapy
26d ago
Enlivex announces DSMB recommendation to initiate Phase II stage of Allocetra
PremiumThe FlyEnlivex announces DSMB recommendation to initiate Phase II stage of Allocetra
2M ago
Enlivex Announces 2024 Shareholder Meeting
Premium
Company Announcements
Enlivex Announces 2024 Shareholder Meeting
2M ago
Enlivex Therapeutics Financials Indicate Net Loss
Premium
Company Announcements
Enlivex Therapeutics Financials Indicate Net Loss
3M ago
Enlivex Therapeutics doses first patient in Phase I/II trial of Allocetra
PremiumThe FlyEnlivex Therapeutics doses first patient in Phase I/II trial of Allocetra
5M ago
Enlivex Webinar to Discuss Breakthrough Immunotherapy
Premium
Company Announcements
Enlivex Webinar to Discuss Breakthrough Immunotherapy
5M ago
Enlivex’s Allocetra Shows Promise in Osteoarthritis Trial
Premium
Company Announcements
Enlivex’s Allocetra Shows Promise in Osteoarthritis Trial
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100